1984
DOI: 10.1159/000206591
|View full text |Cite
|
Sign up to set email alerts
|

Paroxysmal Nocturnal Haemoglobinuria

Abstract: 26 patients, 13 male and 13 female, with paroxysmal nocturnal haemoglobinuria (PNH) are described. The diagnosis was based on the finding of a positive Ham’s test. PNH developed in 4 patients with aplastic anaemia, and 3 patients with established PNH developed marrow hypoplasia during the course of the disease. In 2 cases autoimmune haemolysis was also present; this association has not been described previously. The majority of patients presented with anaemia and dark urine, or with evidence of thrombosis. A h… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
7
0

Year Published

1990
1990
2012
2012

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 25 publications
(7 citation statements)
references
References 17 publications
0
7
0
Order By: Relevance
“…In the Western world there is an apparent increase of PNH since immunosuppression has become standard treatment for patients with severe aplastic anemia (SAA) who are not eligible for bone marrow transplantation (BMT) [2, 4]. The clinical course varies from spontaneous cure to rapid progression and death from thromboembolism or pancytopenia [5, 6, 7]. At the molecular level, PNH is characterized by mutation(s) in the PIG-A gene, which codes for the enzyme essential for the synthesis of the glycosyl-phosphatidylinositol (GPI) anchor, linking several surface proteins to the cell membrane.…”
Section: Introductionmentioning
confidence: 99%
“…In the Western world there is an apparent increase of PNH since immunosuppression has become standard treatment for patients with severe aplastic anemia (SAA) who are not eligible for bone marrow transplantation (BMT) [2, 4]. The clinical course varies from spontaneous cure to rapid progression and death from thromboembolism or pancytopenia [5, 6, 7]. At the molecular level, PNH is characterized by mutation(s) in the PIG-A gene, which codes for the enzyme essential for the synthesis of the glycosyl-phosphatidylinositol (GPI) anchor, linking several surface proteins to the cell membrane.…”
Section: Introductionmentioning
confidence: 99%
“…It is characterized by two major clinical features: chronic intravascular hemolysis with resulting gross hemoglobinuria and diffuse venous thrombosis [2,3]. Since the clinical course is variable, the diagnosis of PNH is often delayed or overlooked [2,3].…”
mentioning
confidence: 99%
“…It is characterized by two major clinical features: chronic intravascular hemolysis with resulting gross hemoglobinuria and diffuse venous thrombosis [2,3]. Since the clinical course is variable, the diagnosis of PNH is often delayed or overlooked [2,3]. When this diagnosis is considered, it can be confirmed by laboratory tests including the sucrose hemolysis test, urine examination for hemosiderin, and the Ham acid hemolysis test [1,2].…”
mentioning
confidence: 99%
“…Stroke due to arterial occlusion has not been clearly documented. 148 Diagnosis is based on erythrocyte lysis during complement activation by acidification (Ham's test) or by lowering ionic strength (sucrose hemolysis test).…”
mentioning
confidence: 99%